Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ


    Brandon Capital

    Independent Governance

    Australian Government
    Australian Super
    Host Plus


Murdoch Children’s Research Institute (MRCI)

Murdoch Childrens Research Institute is the preeminent child health research institute in Australia, and is recognised globally for its child health discoveries.

Centre for Molecular and Medical Research

Our vision is to perform world-class medical research that focuses on the molecular basis of health and disease. The specific areas of our research include cancer, molecular bioscience, metabolic and musculoskeletal medicine, infection and immunity.

Alfred Health

Alfred Health is a leader in health care delivery, improvement, research and education. It strives to achieve best possible health outcomes for patients and the community by integrating clinical practice with research and education.


Government Partners


Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website